A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus.

Worldwide, an estimated 40 million people live with HIV. Two-thirds of this group on the African continent. In 2023, more ...

Worldwide, an estimated 40 million people live with HIV. Two-thirds of this group are on the African continent. In 2023, more ...

Misconceptions about these vaccines stem from misunderstandings about how the immune system and vaccines work. So do they ...

It would be another two years before French researchers would identify a retrovirus as the cause of AIDS, or acquired immunodeficiency syndrome, according to the CDC. It would be another three years ...

Researchers have identified a never-before-seen mechanism that enables HIV-1 to evade the body's natural defenses and use it to support its survival and replication. The 'loophole' is a biological ...

A study of more than 3,000 genomes has traced a gene mutation that confers HIV resistance to a person who lived near the ...

As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

Metformin use in patients with HIV and type 2 diabetes who had at least 2 years of exposure to effective ART showed no significant effect on immune reconstitution.

A prior phase II trial had shown that BCG revaccination in teens led to 45.4% efficacy in reversion from positive to negative ...

Senior Correspondent with New Narratives PELEBO TOWN, Maryland County—Alvin sits under the shade of a mango tree outside a ...